iShares Intermediate-Term Corporate Bond ETF IGIB 深 沪
等待开盘 02-06 09:30:00 美东时间
53.94
+0.210
+0.39%
华盛通- 最 高53.96
- 今 开53.83
- 成交量 315.91万股
- 最 低 53.7964
- 昨 收 53.73
- 总市值 178.81亿
- 52周最高 53.96
- 市盈率 静 --
- 换手率 0.95%
- 52周最低 48.434
- 委 比 1.61%
- 总股本 3.32亿
- 历史最高 53.96
- 量 比 0.97
- 振 幅 0.30%
- 历史最低 37.9972
- 每 手 1
- 风险率 1.57%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Sanegenebio Announces Rnai Global Licensing Collaboration With Genentech
BRIEF-Sanegenebio Announces Rnai Global Licensing Collaboration With Genentech Feb 2 (Reuters) - SANEGENEBIO ANNOUNCES RNAI GLOBAL LICENSING COLLABORATION WITH GENENTECH SANEGENEBIO-WILL RECEIVE UPFRONT PAYMENT OF $200 MILLION, WILL BE ELIGIBLE TO RECEIVE DEVELOPMENT, COMMERCIALIZATION MILESTONE PAY
02-02 21:03
BRIEF-Recordati Announces Collaboration With Moderna For Mrna-3927
BRIEF-Recordati Announces Collaboration With Moderna For Mrna-3927 Jan 29 (Reuters) - Moderna Inc MRNA.O : RECORDATI - ANNOUNCES COLLABORATION WITH MODERNA FOR MRNA-3927 RECORDATI - UNDER DEAL, TO PAY MODERNA $50 MILLION UPFRONT AND $110 MILLION IN MILESTONES RECORDATI: UNDER DEAL, MODERNA IS ALSO E
01-30 06:21
BRIEF-GM Oshawa Assembly's Two Shift Schedule To Begin Feb 2
BRIEF-GM Oshawa Assembly's Two Shift Schedule To Begin Feb 2 Jan 29 (Reuters) - General Motors Co GM.N : GM: OSHAWA ASSEMBLY'S TWO SHIFT SCHEDULE TO BEGIN FEB 2, AT WHICH TIME ABOUT 500 EMPLOYEES WILL BE PLACED ON LAYOFF GM: UNDER COLLECTIVE AGREEMENT, HOURLY SENIORITY EMPLOYEES IMPACTED BY PRODUCTI
01-30 02:22
BRIEF-Janux Therapeutics, Bristol Myers Squibb Sign Exclusive Global License To Develop Tumor-Activated Solid Tumor Therapy
BRIEF-Janux Therapeutics, Bristol Myers Squibb Sign Exclusive Global License To Develop Tumor-Activated Solid Tumor Therapy Jan 22 (Reuters) - Janux Therapeutics Inc JANX.O : JANUX THERAPEUTICS ANNOUNCES COLLABORATION AND EXCLUSIVE WORLDWIDE LICENSE AGREEMENT WITH BRISTOL MYERS SQUIBB TO DEVELOP A N
01-22 20:11
BRIEF-Dawnzera™ (Donidalorsen) Approved In The European Union For Hereditary Angioedema (Hae)
BRIEF-Dawnzera™ (Donidalorsen) Approved In The European Union For Hereditary Angioedema (Hae) Jan 21 (Reuters) - Ionis Pharmaceuticals Inc IONS.O : DAWNZERA™ (DONIDALORSEN) APPROVED IN THE EUROPEAN UNION FOR HEREDITARY ANGIOEDEMA (HAE) IONIS PHARMACEUTICALS INC - ELIGIBLE FOR MILESTONE PAYMENT OF $1
01-21 20:04
Corporate bond liquidity ‘has never been better’ – Goldman’s Jonny Fine
Corporate bond market liquidity has reached unprecedented strength, according to Jonny Fine, Goldman Sachs global head investment grade credit. “Corporate bond liquidity has never been better,” Fine s...
2025-05-07 23:44
Portfolio recommendations to navigate current policy uncertainty – Société Générale
Société Générale analysts have issued a call for investors to pivot away from traditional safe havens like the U.S. dollar (DXY) and instead embrace a “Great Rotation” toward European and Asian assets...
2025-04-17 23:30
It’s not a ‘buy the dip’ for corporate bonds, it’s ‘sell the dip,’ it’s not going to get fixed tomorrow – Saba Capital
Trump’s trade war could accelerate a market “avalanche” of selling in corporate bonds that could lead to bankruptcies happening faster than in previous market crisis, according to Saba Capital Managem...
2025-04-07 23:06
Integrating diverse asset classes is the new ‘cornerstone’ of investing – KKR
Public and private markets are converging asset classes to raise cash, creating an “iPhone moment” for 2025 credit, according to private equity and investment company KKR & Co. In an investor letter, ...
2025-02-07 00:05
公司简介
公司名称
|
iShares 5-10 Year Investment Grade Corporate Bond ETF
|
行业分类
|
Investment Trusts/Mutual Funds
|
业务描述
|
Functions as an exchange traded fund
|
BRIEF-Sanegenebio Announces Rnai Global Licensing Collaboration With Genentech
BRIEF-Sanegenebio Announces Rnai Global Licensing Collaboration With Genentech Feb 2 (Reuters) - SANEGENEBIO ANNOUNCES RNAI GLOBAL LICENSING COLLABORATION WITH GENENTECH SANEGENEBIO-WILL RECEIVE UPFRONT PAYMENT OF $200 MILLION, WILL BE ELIGIBLE TO RECEIVE DEVELOPMENT, COMMERCIALIZATION MILESTONE PAY
02-02 21:03
BRIEF-Recordati Announces Collaboration With Moderna For Mrna-3927
BRIEF-Recordati Announces Collaboration With Moderna For Mrna-3927 Jan 29 (Reuters) - Moderna Inc MRNA.O : RECORDATI - ANNOUNCES COLLABORATION WITH MODERNA FOR MRNA-3927 RECORDATI - UNDER DEAL, TO PAY MODERNA $50 MILLION UPFRONT AND $110 MILLION IN MILESTONES RECORDATI: UNDER DEAL, MODERNA IS ALSO E
01-30 06:21
BRIEF-GM Oshawa Assembly's Two Shift Schedule To Begin Feb 2
BRIEF-GM Oshawa Assembly's Two Shift Schedule To Begin Feb 2 Jan 29 (Reuters) - General Motors Co GM.N : GM: OSHAWA ASSEMBLY'S TWO SHIFT SCHEDULE TO BEGIN FEB 2, AT WHICH TIME ABOUT 500 EMPLOYEES WILL BE PLACED ON LAYOFF GM: UNDER COLLECTIVE AGREEMENT, HOURLY SENIORITY EMPLOYEES IMPACTED BY PRODUCTI
01-30 02:22
BRIEF-Janux Therapeutics, Bristol Myers Squibb Sign Exclusive Global License To Develop Tumor-Activated Solid Tumor Therapy
BRIEF-Janux Therapeutics, Bristol Myers Squibb Sign Exclusive Global License To Develop Tumor-Activated Solid Tumor Therapy Jan 22 (Reuters) - Janux Therapeutics Inc JANX.O : JANUX THERAPEUTICS ANNOUNCES COLLABORATION AND EXCLUSIVE WORLDWIDE LICENSE AGREEMENT WITH BRISTOL MYERS SQUIBB TO DEVELOP A N
01-22 20:11
BRIEF-Dawnzera™ (Donidalorsen) Approved In The European Union For Hereditary Angioedema (Hae)
BRIEF-Dawnzera™ (Donidalorsen) Approved In The European Union For Hereditary Angioedema (Hae) Jan 21 (Reuters) - Ionis Pharmaceuticals Inc IONS.O : DAWNZERA™ (DONIDALORSEN) APPROVED IN THE EUROPEAN UNION FOR HEREDITARY ANGIOEDEMA (HAE) IONIS PHARMACEUTICALS INC - ELIGIBLE FOR MILESTONE PAYMENT OF $1
01-21 20:04
Corporate bond liquidity ‘has never been better’ – Goldman’s Jonny Fine
Corporate bond market liquidity has reached unprecedented strength, according to Jonny Fine, Goldman Sachs global head investment grade credit. “Corporate bond liquidity has never been better,” Fine s...
2025-05-07 23:44
Portfolio recommendations to navigate current policy uncertainty – Société Générale
Société Générale analysts have issued a call for investors to pivot away from traditional safe havens like the U.S. dollar (DXY) and instead embrace a “Great Rotation” toward European and Asian assets...
2025-04-17 23:30
It’s not a ‘buy the dip’ for corporate bonds, it’s ‘sell the dip,’ it’s not going to get fixed tomorrow – Saba Capital
Trump’s trade war could accelerate a market “avalanche” of selling in corporate bonds that could lead to bankruptcies happening faster than in previous market crisis, according to Saba Capital Managem...
2025-04-07 23:06
Integrating diverse asset classes is the new ‘cornerstone’ of investing – KKR
Public and private markets are converging asset classes to raise cash, creating an “iPhone moment” for 2025 credit, according to private equity and investment company KKR & Co. In an investor letter, ...
2025-02-07 00:05
年度
|
派息内容
| 派息日期 |
0.21
|
2026-02-05
| |
0.21
|
2025-12-24
| |
0.21
|
2025-12-04
| |
0.21
|
2025-11-06
| |
0.21
|
2025-10-06
| |
0.21
|
2025-09-05
| |
0.21
|
2025-08-06
| |
0.21
|
2025-07-07
| |
0.20
|
2025-06-05
| |
0.20
|
2025-05-06
| |
0.20
|
2025-04-04
| |
0.20
|
2025-03-06
| |
0.20
|
2025-02-06
| |
0.20
|
2024-12-23
| |
0.19
|
2024-12-05
| |
0.19
|
2024-11-06
| |
0.19
|
2024-10-04
| |
0.19
|
2024-09-06
| |
0.19
|
2024-08-06
| |
0.19
|
2024-07-05
| |
0.19
|
2024-06-07
| |
0.18
|
2024-05-07
| |
0.19
|
2024-04-05
| |
0.18
|
2024-03-07
| |
0.18
|
2024-02-07
| |
0.18
|
2023-12-20
| |
0.17
|
2023-12-07
| |
0.17
|
2023-11-07
| |
0.17
|
2023-10-06
| |
0.16
|
2023-09-08
| |
0.17
|
2023-08-07
| |
0.16
|
2023-07-10
| |
0.16
|
2023-06-07
| |
0.16
|
2023-05-05
| |
0.16
|
2023-04-07
| |
0.15
|
2023-03-07
| |
0.15
|
2023-02-07
| |
0.14
|
2022-12-21
| |
0.14
|
2022-12-07
| |
0.13
|
2022-11-07
| |
0.13
|
2022-10-07
| |
0.13
|
2022-09-08
| |
0.13
|
2022-08-05
| |
0.13
|
2022-07-08
| |
0.12
|
2022-06-07
| |
0.12
|
2022-05-06
| |
0.12
|
2022-04-07
| |
0.11
|
2022-03-07
| |
0.11
|
2022-02-07
| |
0.12
|
2021-12-22
| |
0.24
|
2021-12-07
| |
0.11
|
2021-11-05
| |
0.11
|
2021-10-07
| |
0.11
|
2021-09-08
| |
0.11
|
2021-08-06
| |
0.11
|
2021-07-08
| |
0.11
|
2021-06-07
| |
0.11
|
2021-05-07
| |
0.11
|
2021-04-08
| |
0.12
|
2021-03-05
| |
0.12
|
2021-02-05
| |
0.12
|
2020-12-23
| |
0.13
|
2020-12-07
| |
0.14
|
2020-11-06
| |
0.14
|
2020-10-07
| |
0.13
|
2020-09-08
| |
0.12
|
2020-08-07
| |
0.14
|
2020-07-08
| |
0.14
|
2020-06-05
| |
0.16
|
2020-05-07
| |
0.16
|
2020-04-07
| |
0.16
|
2020-03-06
| |
0.16
|
2020-02-07
| |
0.15
|
2019-12-26
| |
0.16
|
2019-12-06
| |
0.16
|
2019-11-07
| |
0.16
|
2019-10-07
| |
0.17
|
2019-09-09
| |
0.17
|
2019-08-07
| |
0.17
|
2019-07-08
| |
0.18
|
2019-06-07
| |
0.17
|
2019-05-07
| |
0.17
|
2019-04-05
| |
0.17
|
2019-03-07
| |
0.18
|
2019-02-07
| |
0.20
|
2018-12-24
| |
0.18
|
2018-12-07
| |
0.18
|
2018-11-07
| |
0.18
|
2018-10-05
| |
0.16
|
2018-09-10
| |
0.29
|
2018-08-07
| |
0.27
|
2018-07-09
| |
0.26
|
2018-06-07
| |
0.24
|
2018-05-07
| |
0.24
|
2018-04-06
| |
0.24
|
2018-03-07
| |
0.23
|
2018-02-07
| |
0.20
|
2017-12-28
| |
0.23
|
2017-12-07
| |
0.23
|
2017-11-07
| |
0.23
|
2017-10-06
| |
0.23
|
2017-09-08
| |
0.23
|
2017-08-07
| |
0.23
|
2017-07-10
| |
0.23
|
2017-06-07
| |
0.23
|
2017-05-05
| |
0.23
|
2017-04-07
| |
0.23
|
2017-03-07
| |
0.23
|
2017-02-07
| |
0.21
|
2016-12-29
| |
0.22
|
2016-12-07
| |
0.22
|
2016-11-07
| |
0.22
|
2016-10-07
| |
0.22
|
2016-09-08
| |
0.22
|
2016-08-05
| |
0.23
|
2016-07-08
| |
0.22
|
2016-06-07
| |
0.22
|
2016-05-06
| |
0.22
|
2016-04-07
| |
0.23
|
2016-03-07
| |
0.22
|
2016-02-05
| |
0.26
|
2015-12-31
| |
0.22
|
2015-12-07
| |
0.22
|
2015-11-06
| |
0.23
|
2015-10-07
| |
0.22
|
2015-09-08
| |
0.22
|
2015-08-07
| |
0.22
|
2015-07-08
| |
0.22
|
2015-06-05
| |
0.22
|
2015-05-07
| |
0.22
|
2015-04-08
| |
0.22
|
2015-03-06
| |
0.22
|
2015-02-06
| |
0.21
|
2014-12-31
| |
0.22
|
2014-12-05
| |
0.22
|
2014-11-07
| |
0.22
|
2014-10-07
| |
0.22
|
2014-09-08
| |
0.22
|
2014-08-07
| |
0.22
|
2014-07-08
| |
0.23
|
2014-06-06
| |
0.23
|
2014-05-07
| |
0.23
|
2014-04-07
| |
0.24
|
2014-03-07
| |
0.23
|
2014-02-07
| |
0.23
|
2014-01-02
| |
0.24
|
2013-12-06
| |
0.24
|
2013-11-07
| |
0.23
|
2013-10-07
| |
0.24
|
2013-09-09
| |
0.24
|
2013-08-07
| |
0.24
|
2013-07-08
| |
0.24
|
2013-06-07
| |
0.26
|
2013-05-07
| |
0.26
|
2013-04-05
| |
0.27
|
2013-03-07
| |
0.26
|
2013-02-07
| |
0.29
|
2013-01-02
| |
0.27
|
2012-12-07
| |
0.28
|
2012-11-07
| |
0.28
|
2012-10-05
| |
0.28
|
2012-09-10
| |
0.28
|
2012-08-07
| |
0.29
|
2012-07-09
| |
0.30
|
2012-06-07
| |
0.30
|
2012-05-07
| |
0.31
|
2012-04-09
| |
0.32
|
2012-03-07
| |
0.30
|
2012-02-07
| |
0.30
|
2012-01-04
| |
0.34
|
2011-12-07
| |
0.32
|
2011-11-07
| |
0.33
|
2011-10-07
| |
0.32
|
2011-09-08
| |
0.33
|
2011-08-05
| |
0.34
|
2011-07-08
| |
0.34
|
2011-06-07
| |
0.35
|
2011-05-06
| |
0.35
|
2011-04-07
| |
0.36
|
2011-03-07
| |
0.36
|
2011-02-07
| |
0.35
|
2011-01-04
| |
0.43
|
2010-12-07
| |
0.35
|
2010-11-05
| |
0.36
|
2010-10-07
| |
0.36
|
2010-09-08
| |
0.37
|
2010-08-06
| |
0.37
|
2010-07-08
| |
0.35
|
2010-06-07
| |
0.37
|
2010-05-07
| |
0.38
|
2010-04-08
| |
0.38
|
2010-03-05
| |
0.39
|
2010-02-05
| |
0.37
|
2010-01-05
| |
0.39
|
2009-12-07
| |
0.41
|
2009-11-06
| |
0.40
|
2009-10-07
| |
0.40
|
2009-09-08
| |
0.42
|
2009-08-07
| |
0.40
|
2009-07-08
| |
0.44
|
2009-06-05
| |
0.40
|
2009-05-07
| |
0.43
|
2009-04-07
| |
0.41
|
2009-03-06
| |
0.42
|
2009-02-06
| |
0.34
|
2009-01-02
| |
0.39
|
2008-12-05
| |
0.40
|
2008-11-07
| |
0.39
|
2008-10-07
| |
0.35
|
2008-09-08
| |
0.40
|
2008-08-07
| |
0.37
|
2008-07-08
| |
0.38
|
2008-06-06
| |
0.39
|
2008-05-07
| |
0.40
|
2008-04-07
| |
0.35
|
2008-03-07
| |
0.37
|
2008-02-07
| |
0.41
|
2008-01-03
| |
0.42
|
2007-12-07
| |
0.44
|
2007-11-07
| |
0.44
|
2007-10-05
| |
0.44
|
2007-09-10
| |
0.47
|
2007-08-07
| |
0.44
|
2007-07-09
| |
0.45
|
2007-06-07
| |
0.43
|
2007-05-07
| |
0.44
|
2007-04-09
| |
0.40
|
2007-03-07
| |
0.29
|
2007-02-07
|
